Everolimus Based Immunosuppression in Hepatitis C Virus Positive De Novo Liver Transplant Recipients: 24 Month Results from a Randomized Controlled Trial.

被引：0
|
作者：
Saliba, F. [1 ]
Brown, R. S., Jr. [1 ]
Metselaar, H. [1 ]
Beckebaum, S. [1 ]
Duvoux, C. [1 ]
Navasa, M. [1 ]
Dong, G. [2 ]
Lopez, P. [3 ]
Nevens, F. [1 ]
机构：
[1] H2304 Study Grp, Villejuif, France
[2] Novartis Pharmaceut, E Hanover, NJ USA
[3] Novartis Pharma AG, Basel, Switzerland
来源：
LIVER TRANSPLANTATION | 2013年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S100 / S101
页数：2
相关论文
共 50 条
  • [1] EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL
    Saliba, F.
    Metselaar, H. J.
    Beckebaum, S.
    Duvoux, C.
    Navasa, M.
    Dong, G.
    Lopez, P.
    Nevens, F.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S79 - S80
  • [2] Efficacy and Safety of Everolimus Based Immunosuppression in HCV Positive De Novo Liver Transplant Recipients
    Saliba, F.
    De Simone, P.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Jonas, S.
    Sudan, D.
    Fung, J.
    Fischer, L.
    Huang, M. A.
    Foltys, D.
    Wang, Y.
    Sips, C.
    Lopez, P.
    Nevens, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 125 - 126
  • [3] Induction Immunosuppression in Crossmatch Positive Renal Transplant Recipients: Results of a Randomized Controlled Clinical Trial.
    Locke, Jayme E.
    Simpkins, Christopher E.
    Leffell, Mary S.
    Zachary, Andrea A.
    Collins, Vanessa
    Warren, Daniel S.
    Segev, Dorry L.
    Singer, Andrew L.
    Haas, Mark
    Montgomery, Robert A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 241 - 241
  • [4] EVEROLIMUS-BASED IMMUNOSUPPRESSION PROVIDES SUPERIOR RENAL FUNCTION AND COMPARABLE EFFICACY VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMISED CONTROLLED TRIAL
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Kaiser, G. M.
    Saliba, F.
    Jonas, S.
    Duvoux, C.
    Dong, G.
    Junge, G.
    Lopez, P.
    De Simone, P.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S12 - S12
  • [5] A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients
    Chadban, Steven J.
    Eris, Josette Marie
    Kanellis, John
    Pilmore, Helen
    Lee, Po Chang
    Lim, Soo Kun
    Woodcock, Chad
    Kurstjens, Nicol
    Russ, Graeme
    TRANSPLANT INTERNATIONAL, 2014, 27 (03) : 302 - 311
  • [6] Impact of Everolimus-Based Immunosuppression on Efficacy, Safety and Progression of Fibrosis in Hepatitis C Virus Positive De Novo Liver Transplant Recipients: 12 Months Results from H2304 Study
    Beckebaum, S.
    Chavin, K. D.
    Teperman, L.
    Wiederkehr, J.
    Trunecka, P.
    Dong, G.
    Junge, G.
    Lopez, P.
    Duvoux, C.
    TRANSPLANTATION, 2012, 94 (10) : 8 - 8
  • [7] EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS: 12 MONTH RESULTS OF A RANDOMIZED, CONTROLLED STUDY IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS
    Nevens, F.
    De Carlis, L.
    Metselaar, H.
    Saliba, F.
    Beckebaum, S.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Fung, J.
    Jiang, H.
    Junge, G.
    De Simone, P.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S551 - S552
  • [8] Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fung, J.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Koneru, B.
    Huang, M. A.
    Chapman, W. C.
    Foltys, D.
    Witte, S.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (11) : 3008 - 3020
  • [9] Impact of Everolimus Monotherapy on HCV Recurrence in Liver Transplant Recipients: Results of a Randomized Trial.
    Rompianesi, Gianluca
    Montalti, Roberto
    Di Benedetto, Fabrizio
    Cautero, Nicola
    De Ruvo, Nicola
    Ballarin, Roberto
    Tarantino, Giuseppe
    Iemmolo, Rosa Maria
    Gerunda, Giorgio E.
    LIVER TRANSPLANTATION, 2012, 18 : S98 - S98
  • [10] Everolimus with Reduced Tacrolimus Exposure Versus Standard Tacrolimus in Hepatitis C Virus Positive De Novo Liver Transplant Recipients.
    Saliba, F.
    De Simone, P.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Jonas, S.
    Sudan, D.
    Fung, J.
    Fischer, L.
    Huang, M. A.
    Wang, Y.
    Sips, C.
    Lopez, P.
    Nevens, F.
    LIVER TRANSPLANTATION, 2012, 18 : S98 - S98
12345